Short-chain fatty acid-modified hexosamine for tissue-engineering osteoarthritic cartilage

Tissue Engineering - Part A

Volumn 19, Issue 17-18, 2013, Pages 2035-2044

  Coburn, Jeannine M ^a   Wo, Luccie ^a   Bernstein, Nicholas ^a   Bhattacharya, Rahul ^a   Aich, Udayanath ^a   Bingham, Clifton O ^b   Yarema, Kevin J ^a   Elisseeff, Jennifer H ^a  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CARTILAGE; COLLAGEN; DISEASES; GENE EXPRESSION; MOLECULES; PAPERMAKING MACHINERY; PATHOLOGY; REPAIR; TISSUE ENGINEERING;

ANTI-INFLAMMATORIES; ARTICULAR CARTILAGES; EXTRACELLULAR MATRICES; GLYCOSAMINOGLYCANS; HYDROLYSIS PRODUCTS; INFLAMMATORY ARTHRITIS; N-ACETYLGLUCOSAMINE; OSTEOARTHRITIC CARTILAGE;

TISSUE;

3,4,6 O TRIBUTANOYLATED N ACETYLGLUCOSAMINE; AGGRECAN; BUTYRIC ACID; COLLAGEN TYPE 1; COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN POLYSULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; N ACETYLGLUCOSAMINE; PROTEOGLYCAN; UNCLASSIFIED DRUG; BUTYRIC ACID DERIVATIVE; HEXOSAMINE; VOLATILE FATTY ACID;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; BIOACCUMULATION; CARTILAGE CELL; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; DRUG EXPOSURE; EXTRACELLULAR MATRIX; GENE EXPRESSION; HISTOPATHOLOGY; HYDROGEL; IN VITRO STUDY; INFLAMMATION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; TISSUE ENGINEERING; ANIMAL; CARTILAGE; CATTLE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; METHODOLOGY; BOVINAE; DRUG EFFECTS; PROCEDURES;

ACETYLGLUCOSAMINE; ANIMALS; BUTYRATES; CARTILAGE; CATTLE; CELLS, CULTURED; CHONDROCYTES; FATTY ACIDS, VOLATILE; HEXOSAMINES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; OSTEOARTHRITIS; TISSUE ENGINEERING;

EID: 84881173886     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2012.0317     Document Type: Article

References (39)

1. Lawrence, R.C., Felson, D.T., Helmick, C.G., Arnold, L.M., Choi, H., Deyo, R.A., Gabriel, S., Hirsch, R., Hochberg, M.C., Hunder, G.G., Jordan, J.M., Katz, J.N., Kremers, H.M., and Wolfe, F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 58, 26, 2008
2. Mathew, M.P., Tan, E., Shah, S., Bhattacharya, R., Adam Meledeo, M., Huang, J., Espinoza, F.A., and Yarema, K.J. Extracellular and intracellular esterase processing of SCFAhexosamine analogs: Implications for metabolic glycoengineering and drug delivery. Bioorg Med Chem Lett 22, 6929, 2012
3. Malicdan, M.C., Noguchi, S., Tokutomi, T., Goto, Y., Nonaka, I., Hayashi, Y.K., and Nishino, I. Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy. J Biol Chem 287, 2689, 2012
4. Hedbom, E., and Häuselmann, H.J. Molecular aspects of pathogenesis in osteoarthritis: The role of inflammation. Cell Mol Life Sci 59, 45, 2002
5. Benito, M.J., Veale, D.J., FitzGerald, O., van den Berg, W.B., and Bresnihan, B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 64, 1263, 2005
6. Pahl, H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18, 6853, 1999
7. Moos, V., Fickert, S., Muller, B., Weber, U., and Sieper, J. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. J Rheumatol 26, 870, 1999
8. Campbell, C.T., Aich, U., Weier, C.A., Wang, J.J., Choi, S.S., Wen, M.M., Maisel, K., Sampathkumar, S.-G., and Yarema, K.J. Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells. J Med Chem 51, 8135, 2008
9. Meutermans, W., Le, G.T., and Becker, B. Carbohydrates as scaffolds in drug discovery. ChemMedChem 1, 1164, 2006
10. Elmouelhi, N., Aich, U., Paruchuri, V.D., Meledeo, M.A., Campbell, C.T., Wang, J.J., Srinivas, R., Khanna, H.S., and Yarema, K.J. Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery. J Med Chem 52, 2515, 2009
11. Rutjes, A.W., Juni, P., da Costa, B.R., Trelle, S., Nuesch, E., and Reichenbach, S. Viscosupplementation for osteoarthritis of the knee: A systematic review and meta-analysis. Ann Intern Med 157, 180, 2012
12. Aich, U., Campbell, C.T., Elmouelhi, N., Weier, C.A., Sampathkumar, S.G., Choi, S.S., and Yarema, K.J. Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxicity and MUC1 suppression. ACS Chem Biol 3, 230, 2008
13. Kim, E.J., Sampathkumar, S.G., Jones, M.B., Rhee, J.K., Baskaran, G., Goon, S., and Yarema, K.J. Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells. J Biol Chem 279, 18342, 2004
14. Kim, T.K., Sharma, B., Williams, C.G., Ruffner, M.A., Malik, A., McFarland, E.G., and Elisseeff, J.H. Experimental model for cartilage tissue engineering to regenerate the zonal organization of articular cartilage. Osteoarthritis Cartilage 11, 653, 2003
15. Kim, Y.-J., Sah, R.L.Y., Doong, J.-Y.H., and Grodzinsky, A.J. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174, 168, 1988
16. Farndale, R.W., Buttle, D.J., and Barrett, A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883, 173, 1986
17. Woessner, J.F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93, 440, 1961
18. Livak, K.J., and Schmittgen, T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) Method. Methods 25, 402, 2001
19. Stokes, D.G., Liu, G., Coimbra, I.B., Piera-Velazquez, S., Crowl, R.M., and Jiménez, S.A. Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum 46, 404, 2002
20. Sharma, B., Williams, C.G., Kim, T.K., Sun, D., Malik, A., Khan, M., Leong, K., and Elisseeff, J.H. Designing zonal organization into tissue-engineered cartilage. Tissue Eng 13, 405, 2007
21. Bryant, S.J., and Anseth, K.S. Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed Mater Res 59, 63, 2002
22. Lee, W.K., Ichi, T., Ooya, T., Yamamoto, T., Katoh, M., and Yui, N. Novel poly(ethylene glycol) scaffolds crosslinked by hydrolyzable polyrotaxane for cartilage tissue engineering. J Biomed Mater Res A 67, 1087, 2003
23. Lin-Gibson, S., Bencherif, S., Cooper, J.A., Wetzel, S.J., Antonucci, J.M., Vogel, B.M., Horkay, F., and Washburn, N.R. Synthesis and characterization of PEG dimethacrylates and their hydrogels. Biomacromolecules 5, 1280, 2004
24. Elisseeff, J., McIntosh, W., Anseth, K., Riley, S., Ragan, P., and Langer, R. Photoencapsulation of chondrocytes in poly(ethylene oxide)-based semi-interpenetrating networks. J Biomed Mater Res 51, 164, 2000
25. Sims, C.D., Butler, P.E., Casanova, R., Lee, B.T., Randolph, M.A., Lee, W.P., Vacanti, C.A., and Yaremchuk, M.J. Injectable cartilage using polyethylene oxide polymer substrates. Plast Reconstr Surg 98, 843, 1996
26. Coburn, J.M., Bernstein, N., Bhattacharya, R., Aich, U., Yarema, K.J., and Elisseeff, J.H. Differential response of chondrocytes and chondrogenic-induced mesenchymal stem cells to C1-OH tributanoylated N-acetylhexosamines. PLoS One 8, e58899, 2013
27. Prabhakar, V., and Sasisekharan, R. The biosynthesis and catabolism of galactosaminoglycans. In: Nicola, V., ed. Advances in Pharmacology, Volume 53. Academic Press, 2006, p. 69
28. Zhang, X., Smith, D.L., Meriin, A.B., Engemann, S., Russel, D.E., Roark, M., Washington, S.L., Maxwell, M.M., Marsh, J.L., Thompson, L.M., Wanker, E.E., Young, A.B., Housman, D.E., Bates, G.P., Sherman, M.Y., and Kazantsev, A.G. A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neu- rodegeneration in vivo. Proc Natl Acad Sci U S A 102, 892, 2005
29. Friman, S., Arns, W., Nashan, B., Vincenti, F., Banas, B., Budde, K., Cibrik, D., Chan, L., Klempnauer, J., Mulgaonkar, S., Nicholson, M., Wahlberg, J., Wissing, K.M., Abrams, K., Witte, S., and Woodle, E.S. Sotrastaurin, a novel small molecule inhibiting protein-kinase C: Randomized phase II study in renal transplant recipients. Am J Translant 11, 1444, 2011
30. MacMillan, K.S., Naidoo, J., Liang, J., Melito, L., Williams, N.S., Morlock, L., Huntington, P.J., Estill, S.J., Longgood, J., Becker, G.L., McKnight, S.L., Pieper, A.A., De Brabander, J.K., and Ready, J.M. Development of proneurogenic, neuroprotective small molecules. J Am Chem Soc 133, 1428, 2011
31. Hong, C.C., and Yu, P.B. Applications of small molecule BMP inhibitors in physiology and disease. Cytokine Growth Factor Rev 20, 409, 2009
32. Milne, J.C., Lambert, P.D., Schenk, S., Carney, D.P., Smith, J.J., Gagne, D.J., Jin, L., Boss, O., Perni, R.B., Vu, C.B., Bemis, J.E., Xie, R., Disch, J.S., Ng, P.Y., Nunes, J.J., Lynch, A.V., Yang, H., Galonek, H., Israelian, K., Choy, W., Iffland, A., Lavu, S., Medvedik, O., Sinclair, D.A., Olefsky, J.M., Jirousek, M.R., Elliott, P.J., and Westphal, C.H. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712, 2007
33. Calamini, B., Silva, M.C., Madoux, F., Hutt, D.M., Khanna, S., Chalfant, M.A., Saldanha, S.A., Hodder, P., Tait, B.D., Garza, D., Balch, W.E., and Morimoto, R.I. Small-molecule proteostasis regulators for protein conformational diseases. Nat Chem Biol 8, 185, 2012
34. Mow, V.C., Ratcliffe, A., and Poole, A.R. Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials 13, 67, 1992
35. Shikhman, A.R., Kuhn, K., Alaaeddine, N., and Lotz, M. NAcetylglucosamine prevents IL-1b-mediated activation of human chondrocytes. J Immunol 166, 5155, 2001
36. Hwang, Y.P., Kim, H.G., Han, E.H., Choi, J.H., Park, B.H., Jung, K.H., Shin, Y.C., and Jeong, H.G. N-Acetylglucosamine suppress collagenases activation in ultraviolet B-irradiated human dermal fibroblasts: Involvement of calcium ions and mitogen-activated protein kinases. J Dermatol Sci 63, 93, 2011
37. Shikhman, A.R., Amiel, D., D'Lima, D., Hwang, S.B., Hu, C., Xu, A., Hashimoto, S., Kobayashi, K., Sasho, T., and Lotz, M.K. Chondroprotective activity of N-acetylglucosamine in rabbits with experimental osteoarthritis. Ann Rheum Dis 64, 89, 2005
38. Chabane, N., Zayed, N., Afif, H., Mfuna-Endam, L., Benderdour, M., Boileau, C., Martel-Pelletier, J., Pelletier, J.P., Duval, N., and Fahmi, H. Histone deacetylase inhibitors suppress interleukin-1b-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthritis Cartilage 16, 1267, 2008
39. Stephens, M.B., Beutler, A.I., and O'Connor, F.G. Musculoskeletal injections: A review of the evidence. Am Fam Physician 78, 971, 2008.